BAG3 and cardiomyopathy: There is an increased prevalence of rare variants (BAG3, LMNA, MYH7, TCAP, TNNT2, and TTN), particularly TTNtv, in adult and pediatric cancer patients with cancer therapy-induced cardiomyopathy (73).